Enhanced therapeutic efficacy of doxorubicin against multidrug-resistant breast cancer with reduced cardiotoxicity

References

• Aggarwal V, Tuli HS, Tania M, et al. (2022). Molecular mechanisms of action of epigallocatechin gallate in cancer: recent trends and advancement. Semin Cancer Biol 80:1–13.
   PubMed Web of Science ®Google Scholar
• Cheng T, Liu J, Ren J, et al. (2016). Green tea catechin-based complex micelles combined with doxorubicin to overcome cardiotoxicity and multidrug resistance. Theranostics 6:1277–92.
   PubMed Web of Science ®Google Scholar
• Choi PS, Lee JY, Park JH, Kim SW. (2018). Synthesis and evaluation of (68) Ga-HBED-CC-EDBE-folate for positron-emission tomography imaging of overexpressed folate receptors on CT26 tumor cells. J Labelled Comp Radiopharm 61:4–10.
   PubMed Web of Science ®Google Scholar
• Fathi M, Majidi S, Zangabad PS, et al. (2018). Chitosan-based multifunctional nanomedicines and theranostics for targeted therapy of cancer. Med Res Rev 38:2110–36.
   PubMed Web of Science ®Google Scholar
• Fischer A, Zhang P, Ouyang Y, et al. (2022). DNA-tetrahedra corona-modified hydrogel microcapsules: "Smart" ATP-or microRNA-responsive drug carriers. Small 18:e2204108.
   PubMed Web of Science ®Google Scholar
• Gan RY, Li HB, Sui ZQ, Corke H. (2018). Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): an updated review. Crit Rev Food Sci Nutr 58:924–41.
   PubMed Web of Science ®Google Scholar
• Gao X, Huang H, Pan C, et al. (2022). Disulfiram/copper induces immunogenic cell death and enhances CD47 blockade in hepatocellular carcinoma. Cancers (Basel) 14:4715.
   PubMed Web of Science ®Google Scholar
• Heo GS, Detering L, Luehmann HP, et al. (2019). Folate Receptor alpha-targeted (89)Zr-M9346A immuno-PET for image-guided intervention with mirvetuximab soravtansine in triple-negative breast cancer. Mol Pharm 16:3996–4006.
   PubMedGoogle Scholar
• Hu XY, Gao L, Mosel S, et al. (2018). From supramolecular vesicles to micelles: controllable construction of tumor-targeting nanocarriers based on host-guest interaction between a Pillar[5]arene-based prodrug and a RGD-sulfonate guest. Small 14:e1803952.
   PubMed Web of Science ®Google Scholar
• Jiao Y, Zhang Q, Zhang J, et al. (2022). Platelet-rich plasma ameliorates lipopolysaccharide-induced cardiac injury by inflammation and ferroptosis regulation. Front Pharmacol 13:1026641.
   PubMed Web of Science ®Google Scholar
• Jin Q, Deng Y, Chen X, Ji J. (2019). Rational design of cancer nanomedicine for simultaneous stealth surface and enhanced cellular uptake. ACS Nano 13:954–77.
   PubMed Web of Science ®Google Scholar
• Kan X, Zhou G, Zhang F, et al. (2022). Enhanced efficacy of direct immunochemotherapy for hepatic cancer with image-guided intratumoral radiofrequency hyperthermia. J Immunother Cancer 10:e005619.
   PubMed Web of Science ®Google Scholar
• Koual M, Tomkiewicz C, Cano-Sancho G, et al. (2020). Environmental chemicals, breast cancer progression and drug resistance. Environ Health 19:117.
   PubMed Web of Science ®Google Scholar
• Li Q, Zhou Y, He W, et al. (2021). Platelet-armored nanoplatform to harmonize janus-faced IFN-γ against tumor recurrence and metastasis. J Control Release 338:33–45.
   PubMed Web of Science ®Google Scholar
• Lin L, Xie S, Zhao Y, et al. (2023). Ultrasound-induced destruction of heparin-loaded microbubbles attenuates L-arginine-induced acute pancreatitis. Eur J Pharm Sci 180:106318.
   PubMed Web of Science ®Google Scholar
• Liu Y, Guo K, Ding M, et al. (2022). Engineered magnetic polymer nanoparticles can ameliorate breast cancer treatment inducing pyroptosis-starvation along with chemotherapy. ACS Appl Mater Interfaces 14:42541–57.
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Kezuka C, Morikawa Y, et al. (2015). Up-regulation of carbonyl reductase 1 renders development of doxorubicin resistance in human gastrointestinal cancers. Biol Pharm Bull 38:1309–19.
   PubMed Web of Science ®Google Scholar
• Migliorini F, Cini E, Dreassi E, et al. (2022). A pH-responsive crosslinker platform for antibody-drug conjugate (ADC) targeting delivery. Chem Commun (Camb) 58:10532–5.
   PubMed Web of Science ®Google Scholar
• Palmeira A, Sousa E, Vasconcelos MH, Pinto MM. (2012). Three decades of P-gp inhibitors: skimming through several generations and scaffolds. Curr Med Chem 19:1946–2025.
   PubMed Web of Science ®Google Scholar
• Patra A, Satpathy S, Naik PK, et al. (2022). Folate receptor-targeted PLGA-PEG nanoparticles for enhancing the activity of genistein in ovarian cancer. Artif Cells Nanomed Biotechnol 50:228–39.
   PubMed Web of Science ®Google Scholar
• Peer D, Karp JM, Hong S, et al. (2007). Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751–60.
   PubMed Web of Science ®Google Scholar
• Qi X, Wang J, Fei F, et al. (2023). Myricetin-loaded nanomicelles protect against cisplatin-induced acute kidney injury by inhibiting the DNA damage-cGAS-STING signaling pathway. Mol Pharm 20:136–46.
   PubMedGoogle Scholar
• Ren X, Wang N, Zhou Y, et al. (2021). An injectable hydrogel using an immunomodulating gelator for amplified tumor immunotherapy by blocking the arginase pathway. Acta Biomater 124:179–90.
   PubMed Web of Science ®Google Scholar
• Renu K, V G A, P B TP, Arunachalam S. (2018). Molecular mechanism of doxorubicin-induced cardiomyopathy – an update. Eur J Pharmacol 818:241–53.
   PubMed Web of Science ®Google Scholar
• Satonaka H, Ishida K, Takai M, et al. (2017). (-)-Epigallocatechin-3-gallate down-regulates doxorubicin-induced overexpression of P-glycoprotein through the coordinate inhibition of PI3K/Akt and MEK/ERK signaling pathways. Anticancer Res 37:6071–7.
   PubMed Web of Science ®Google Scholar
• Shi J, Liu Y, Wang L, et al. (2014). A tumoral acidic pH-responsive drug delivery system based on a novel photosensitizer (fullerene) for in vitro and in vivo chemo-photodynamic therapy. Acta Biomater 10:1280–91.
   PubMed Web of Science ®Google Scholar
• Shubhra QTH, Guo K, Liu Y, et al. (2021). Dual targeting smart drug delivery system for multimodal synergistic combination cancer therapy with reduced cardiotoxicity. Acta Biomater 131:493–507.
   PubMed Web of Science ®Google Scholar
• Turhon M, Maimaiti A, Gheyret D, et al. (2022). An immunogenic cell death-related regulators classification patterns and immune microenvironment infiltration characterization in intracranial aneurysm based on machine learning. Front Immunol 13:1001320.
   PubMed Web of Science ®Google Scholar
• Ungarala R, Munikumar M, Sinha SN, et al. (2022). Assessment of antioxidant, immunomodulatory activity of oxidised epigallocatechin-3-gallate (green tea polyphenol) and its action on the main protease of SARS-CoV-2-An in vitro and in silico approach. Antioxidants (Basel) 11:294.
   PubMedGoogle Scholar
• Unno T, Araki Y, Inagaki S, et al. (2021). Fructooligosaccharides increase in plasma concentration of (-)-epigallocatechin-3-gallate in rats. J Agric Food Chem 69:14849–55.
   PubMed Web of Science ®Google Scholar
• Varela-López A, Battino M, Navarro-Hortal MD, et al. (2019). An update on the mechanisms related to cell death and toxicity of doxorubicin and the protective role of nutrients. Food Chem Toxicol 134:110834.
   PubMed Web of Science ®Google Scholar
• Wang X, Li X, Liang X, et al. (2018). ROS-responsive capsules engineered from green tea polyphenol-metal networks for anticancer drug delivery. J Mater Chem B 6:1000–10.
   PubMed Web of Science ®Google Scholar
• Xi D, Xu N, Xia X, et al. (2022). Strong pi-pi stacking stabilized nanophotosensitizers: improving tumor retention for enhanced therapy for large tumors in mice. Adv Mater 34:e2106797.
   PubMed Web of Science ®Google Scholar
• Yildirim C, Cangi S, Orkmez M, et al. (2023). Sinapic acid attenuated cisplatin-induced cardiotoxicity by inhibiting oxidative stress and inflammation with GPX4-mediated NF-kB modulation. Cardiovasc Toxicol 23:10–22.
   PubMed Web of Science ®Google Scholar
• Zhan M, Qiu J, Fan Y, et al. (2023). Phosphorous dendron micelles as a nanomedicine platform for cooperative tumor chemoimmunotherapy via synergistic modulation of immune cells. Adv Mater 35:e2208277.
   PubMed Web of Science ®Google Scholar
• Zhang J, Sun X, Zhao X, et al. (2022). Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy. Acta Pharm Sin B 12:3694–709.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang N, Li Q, et al. (2021). A two-pronged photodynamic nanodrug to prevent metastasis of basal-like breast cancer. Chem Commun (Camb) 57:2305–8.
   PubMed Web of Science ®Google Scholar
• Ziaunys M, Smirnovas V. (2022). Exploring epigallocatechin-3-gallate autoxidation products: specific incubation times required for emergence of anti-amyloid properties. Antioxidants 11:1887.
   Web of Science ®Google Scholar